Renal Cell Carcinoma Stage III Clinical Trial
Official title:
Resection of Renal Cell Carcinoma and Stage IV Inferior Vena Cava Thrombus Without Thoracotomy: A Case Series and Literature Review.
| Verified date | April 2020 |
| Source | Attikon Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Assessment of short-term outcomes of radical nephrectomy combined with IVC thrombectomy with a novel technique without thoracotomy: single center case series.
| Status | Completed |
| Enrollment | 3 |
| Est. completion date | March 31, 2020 |
| Est. primary completion date | March 31, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Adult patients - Documented radiological and/or pathological diagnosis of renal cell carcinoma with level IV tumor thrombus Exclusion Criteria: - American Anesthesia Association (ASA) Class V and/or any contraindications to general anesthesia |
| Country | Name | City | State |
|---|---|---|---|
| Greece | Attikon University Hospital | Chaidari |
| Lead Sponsor | Collaborator |
|---|---|
| Attikon Hospital |
Greece,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Short term mortality rate | Percentage of patients` postoperative deaths | 30 days | |
| Secondary | Short term major complications` rate | Incidence of Clavien/Dindo grade 3 or more postoperative complications | 30 days | |
| Secondary | Recurrence rate | Rate of local or systemic recurrence | 27 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT06377722 -
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer
|
Phase 2 |